G. Halperin

1.6k total citations
71 papers, 1.4k citations indexed

About

G. Halperin is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Halperin has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 33 papers in Molecular Biology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Halperin's work include Cholesterol and Lipid Metabolism (28 papers), Fatty Acid Research and Health (14 papers) and Lipoproteins and Cardiovascular Health (12 papers). G. Halperin is often cited by papers focused on Cholesterol and Lipid Metabolism (28 papers), Fatty Acid Research and Health (14 papers) and Lipoproteins and Cardiovascular Health (12 papers). G. Halperin collaborates with scholars based in Israel, United States and Sweden. G. Halperin's co-authors include Y. Stein, Oliver Stein, Y. Dabach, G. Hollander, Olga Stein, Yechezkiel Stein, M. Ben-Naim, S Gatt, Thomas Olivecrona and Shmuel Shaltiel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

G. Halperin

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Halperin Israel 22 644 583 289 227 180 71 1.4k
A M Fogelman United States 15 580 0.9× 491 0.8× 127 0.4× 153 0.7× 161 0.9× 21 1.7k
Rahul Kuver United States 21 555 0.9× 602 1.0× 238 0.8× 103 0.5× 90 0.5× 38 1.8k
S. Basu India 18 651 1.0× 365 0.6× 157 0.5× 280 1.2× 58 0.3× 35 1.4k
David W. A. Beno United States 21 491 0.8× 176 0.3× 95 0.3× 87 0.4× 72 0.4× 54 1.4k
Peter Ove United States 24 894 1.4× 240 0.4× 93 0.3× 238 1.0× 111 0.6× 54 1.7k
Martin J. Griffin United States 24 889 1.4× 77 0.1× 403 1.4× 216 1.0× 63 0.3× 58 1.6k
John I. Germershausen United States 16 454 0.7× 306 0.5× 57 0.2× 75 0.3× 38 0.2× 27 1.1k
Andrea Verhagen United States 14 738 1.1× 472 0.8× 104 0.4× 125 0.6× 64 0.4× 19 1.5k
M S Levin United States 14 727 1.1× 113 0.2× 66 0.2× 37 0.2× 120 0.7× 15 1.0k
J.D. Priddle United Kingdom 19 785 1.2× 233 0.4× 70 0.2× 28 0.1× 67 0.4× 40 1.4k

Countries citing papers authored by G. Halperin

Since Specialization
Citations

This map shows the geographic impact of G. Halperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Halperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Halperin more than expected).

Fields of papers citing papers by G. Halperin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Halperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Halperin. The network helps show where G. Halperin may publish in the future.

Co-authorship network of co-authors of G. Halperin

This figure shows the co-authorship network connecting the top 25 collaborators of G. Halperin. A scholar is included among the top collaborators of G. Halperin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Halperin. G. Halperin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halperin, G., et al.. (2013). Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies. PDA Journal of Pharmaceutical Science and Technology. 67(1). 74–78.
2.
Zauberman, Ayelet, Yehuda Flashner, Yinon Levy, et al.. (2013). YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. PLoS ONE. 8(12). e83560–e83560. 9 indexed citations
3.
Flashner, Yehuda, Morly Fisher, Avital Tidhar, et al.. (2010). The search for early markers of plague: evidence for accumulation of solubleYersinia pestisLcrV in bubonic and pneumonic mouse models of disease. FEMS Immunology & Medical Microbiology. 59(2). 197–206. 20 indexed citations
4.
Mendel, Itzhak, et al.. (2010). A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease. Journal of Neuroimmunology. 226(1-2). 126–135. 13 indexed citations
5.
Zauberman, Ayelet, Avital Tidhar, Yinon Levy, et al.. (2009). Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague. PLoS ONE. 4(6). e5938–e5938. 38 indexed citations
6.
7.
Stein, Olga, Y. Dabach, M. Ben-Naim, G. Halperin, & Yechezkiel Stein. (2008). Effects of oleic acid and macrophage recruitment on cholesterol efflux in cell culture and in vivo. Nutrition Metabolism and Cardiovascular Diseases. 18(9). 596–601. 7 indexed citations
8.
Stein, Yechezkiel, Olga Stein, Y. Dabach, G. Halperin, & M. Ben-Naim. (2004). LXR activation and cholesterol efflux from a lipoprotein depot in vivo. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1686(1-2). 24–29. 6 indexed citations
9.
Stein, Oliver, Y. Dabach, G. Halperin, M. Ben-Naim, & Y. Stein. (2003). Calorie restriction in mice does not affect LDL reverse cholesterol transport in vivo. Biochemical and Biophysical Research Communications. 308(1). 29–34. 7 indexed citations
10.
Stein, Olga, Y. Dabach, M. Ben-Naim, et al.. (2003). In CCR2−/− mice monocyte recruitment and egress of LDL cholesterol in vivo is impaired. Biochemical and Biophysical Research Communications. 300(2). 477–481. 9 indexed citations
11.
Stein, Oliver, Y. Dabach, G. Hollander, et al.. (2002). Reverse cholesterol transport in mice expressing simian cholesteryl ester transfer protein. Atherosclerosis. 164(1). 73–78. 12 indexed citations
12.
Halperin, G., Moses Elisaf, Eran Leitersdorf, & Dror Harats. (2000). A new method for determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 742(2). 345–352. 10 indexed citations
13.
Stein, Olga, Y. Dabach, G. Hollander, et al.. (1999). High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Atherosclerosis. 144(2). 367–374. 16 indexed citations
14.
Stein, Oliver, Y. Dabach, G. Hollander, et al.. (1998). Dexamethasone impairs cholesterol egress from a localized lipoprotein depot in vivo. Atherosclerosis. 137(2). 303–310. 12 indexed citations
15.
Barasch, Dinorah, et al.. (1997). Mass spectral determination of the configuration of 17β-tetrahydropyranyloxy-19-norandrostan-3β-ol. International Journal of Mass Spectrometry and Ion Processes. 167-168. 79–85. 1 indexed citations
16.
Stein, Oliver, Y. Dabach, G. Hollander, et al.. (1996). Relative resistance of the hamster to aortic atherosclerosis in spite of prolonged vitamin E deficiency and dietary hypercholesterolemia. Putative effect of increased HDL?. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1299(2). 216–222. 15 indexed citations
17.
Stein, Oliver, Y. Dabach, G. Hollander, et al.. (1989). Cholesterol removal by peritoneal lavage with phospholipid-HDL apoprotein mixtures in hypercholesterolemic hamsters. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1006(1). 144–146. 5 indexed citations
18.
Stein, Oliver, K. Oette, D. Haratz, G. Halperin, & Y. Stein. (1988). Sphingomyelin liposomes with defined fatty acids: metabolism and effects on reverse cholesterol transport. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 960(3). 322–333. 19 indexed citations
19.
Stein, Y., Y. Dabach, G. Hollander, G. Halperin, & Oliver Stein. (1983). Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 752(1). 98–105. 160 indexed citations
20.
Halperin, G., et al.. (1974). Bromination of methyl-3-oxo-5.beta.-cholanate at C-2. The Journal of Organic Chemistry. 39(20). 3047–3048. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A M Fogelman Breakdown of academic impact, for papers by Rahul Kuver Breakdown of academic impact, for papers by S. Basu Breakdown of academic impact, for papers by David W. A. Beno Breakdown of academic impact, for papers by Peter Ove Breakdown of academic impact, for papers by Martin J. Griffin Breakdown of academic impact, for papers by John I. Germershausen Breakdown of academic impact, for papers by Andrea Verhagen Breakdown of academic impact, for papers by M S Levin Breakdown of academic impact, for papers by J.D. Priddle
Rankless by CCL
2026